• Opko Health Inc., of Miami, reported that its Barcelona-based subsidiary, Pharmadiet S.L.U., received final marketing approval from Spain’s health authority (Agencia Española de Medicamentos y Productos Sanitarios) for commercialization of its oral and injectable formulations of citicoline.